Drug policy reform in historical perspective: movements and mechanisms.

Drug Alcohol Rev

Alcohol Research Group, Medical Research Institute of San Francisco, 2000 Hearst Avenue, Berkeley, California, 94709, USA.

Published: October 2012

The use of psychoactive drugs is regarded by many as a basic human drive, but it is one that induces a variety of societal responses to curb it. The present review examines two aspects of government policy on drugs: first, the influence of social movements on drug policy; and secondly, the choices for constraining drug use as an alternative to total prohibition. Addiction is essentially a repeated behaviour which is viewed as excessive or harmful. As such, it has many similarities with a wide range of human behaviours. With the concept of addiction becoming progressively banalized, there is the possibility of a more natural debate about decriminalization and legalization of drugs in terms of a balance between harm and benefits. The current public debate may create a climate for serious political consideration of the strategies.

Download full-text PDF

Source
http://dx.doi.org/10.1080/09595239100185051DOI Listing

Publication Analysis

Top Keywords

drug policy
8
policy reform
4
reform historical
4
historical perspective
4
perspective movements
4
movements mechanisms
4
mechanisms psychoactive
4
psychoactive drugs
4
drugs regarded
4
regarded basic
4

Similar Publications

Drug use among men is a significant public health concern in China, with compulsory drug treatment centers being the primary approach. Police officers in these centers play a crucial role in shaping the interactions and experiences of men who use drugs (MWUD). However, little research exists on the attitudes of police officers toward MWUD in China.

View Article and Find Full Text PDF

Patients with diabetes are at increased risk of HBV infection; however, the effects of HBV infection and anti-HBV therapy on the management of type 1 diabetes (T1D), type 2 diabetes (T2D), and latent autoimmune diabetes in adults (LADA) remain unclear. From 2016 to 2023, we recruited a multicenter cohort of 355 HBV-infected inpatients, including 136 with T1D, 140 with T2D, and 79 with LADA. The control group included 525 HBV-uninfected inpatients, comparing 171 with T1D, 204 with T2D and 150 with LADA.

View Article and Find Full Text PDF

Background: Evolving evidence suggests that patients undergoing treatment with Janus kinase inhibitors (JAKi) may face an increased risk of cardiovascular events, malignancies, and serious infections.

Objectives: We assessed cardiovascular, malignancy, and serious infection risks associated with JAKi use compared to tumor necrosis factor inhibitor (TNFi) use, which served as the active comparator, in patients with rheumatoid arthritis (RA) or ulcerative colitis (UC).

Methods: This study emulated a target trial using South Korea's nationwide claims database (2013-2023).

View Article and Find Full Text PDF

This study aimed to evaluate the effectiveness of direct-acting antivirals (DAAs) on hepatitis C virus (HCV) hospitalisation trends in Italy, the country with not only the highest burden of HCV-related disease but also the highest number of patients treated for chronic HCV infection in Europe. Incident hospital discharge records in Italy from 2012 to 2019 that included a liver cirrhosis diagnosis without mention of alcohol, hepatocellular carcinoma (HCC), HCV and liver cirrhosis without mention of alcohol and/or HCC, cirrhosis with mention of alcohol, as defined by the International Classification of Diseases (ICD-9-CM) were reviewed. An interrupted time series analysis compared the incidence of cirrhosis and HCC before and after the introduction of DAAs (Year 2015).

View Article and Find Full Text PDF

Introduction: Multidrug resistant (MDR) Gram-negative bacterial infections are considered a major public health threat. The objectives of this study were to describe the epidemiology, potential contributing factors, and antimicrobial resistance patterns associated with infections caused by MDR Gram-negative bacteria (GNB) in non-immunocompromised children and adolescents.

Methods: This was a retrospective observational study conducted at the American University of Beirut Medical Center (AUBMC) from 2009 to 2017.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!